Cari Gallman
BMYCari Gallman serves as EVP, General Counsel at Bristol-Myers Squibb Company (BMY). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.
Cari Gallman's Insider Trading at Bristol-Myers Squibb Company (BMY)
Buys
0 · $0.00
Sells
6 · $397.6K
Total Shares Bought
0
Total Shares Sold
7,543
Related Insiders
Benjamin Hickey
President, RayzeBio Org.
BMYSell · Feb 1, 2026
Gregory Scott Meyers
EVP, Chief Digital & Tech Off.
BMYSell · Feb 1, 2026
BOERNER CHRISTOPHER S.
Chief Executive Officer
BMYSell · Nov 1, 2025
Karin Shanahan
EVP, Chief Supply Chain & Ops
BMYSell · Nov 1, 2025
David Elkins V
EVP, Chief Financial Officer
BMYSell · Sep 2, 2025
Bartie Wendy Short
EVP, Corporate Affairs
BMYSell · Sep 1, 2025
Samit Hirawat
EVP,Chief Med.Offr.,Drug Dev.
BMYBuy · Apr 25, 2025
Karin Shanahan
EVP, Glob. Prod. Dev. & Supply
BMYSell · Apr 1, 2025